Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 8,72 | 8,72 | 2019-03-31 |
| Recall Capital Nordic AB | 6,60 | 6,60 | 2019-04-11 |
| Thord Wilkne | 5,08 | 5,08 | 2019-03-31 |
| Nordnet Pensionsförsäkring | 3,38 | 3,38 | 2019-03-31 |
| Ramin Hossein Khatiri | 2,43 | 2,43 | 2019-03-31 |
| Kerstin Uvnäs Moberg | 2,06 | 2,06 | 2019-03-31 |
| Arne Ryberg | 2,06 | 2,06 | 2019-03-31 |
| Henrik Hahn | 1,50 | 1,50 | 2019-03-31 |
| Humard AB | 1,31 | 1,31 | 2019-03-31 |
| Edvard Welanders Stiftelse | 0,97 | 0,97 | 2019-03-31 |
2019-06-19 Årsstämma 2018
2019-08-16 Delårsrapport 2019-Q2
2019-11-08 Delårsrapport 2019-Q3
2020-02-27 Bokslutskommuniké 2019